Recombinant tissue plasminogen activator is a useful alternative to heparin in priming Quinton Permcath

American Journal of Kidney Diseases

Volumn 35, Issue 1, 2000, Pages 130-136

  Schenk, Peter ^a   Rosenkranz, Alexander R ^a   Wölfl, Gabriele ^a   Hörl, Walter H ^a   Traindl, Otto ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Catheter performance; Hemodialysis (HD); Heparin; Permcath; Recombinant tissue plasminogen activator (rTPA)

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; HEPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD FLOW; CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; DIALYSIS; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS; HUMAN; MALE; THROMBOSIS PREVENTION; VASCULAR ACCESS;

EID: 0033970005     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(00)70311-8     Document Type: Article

References (25)

1. CB Anderson JR Codd RA Graff MA Groce HR Harter WT Newton Cardiac failure and upper extremity arteriovenous dialysis fistulas. Case reports and a review of the literature Arch Intern Med 136 1976 292 297
2. AH Morsy M Kulbaski C Chen H Isiklar AB Lumsden Incidence and characteristics of patients with hand ischemia after a hemodialysis access procedure J Surg Res 74 1998 8 10
3. JB Selby Jr TL Pruett FB Westervelt Jr CJ Tegtmeyer CL Poole Treatment of hemodialysis fistula pseudoaneurysms with detachable balloons: Technique and preliminary results J Vasc Interv Radiol 3 1992 505 510
4. KR Patel FA Chan RJ Batista RH Clauss True venous aneurysms and arterial “steal” secondary to arteriovenous fistulae for dialysis J Cardiovasc Surg 33 1992 185 188
5. RY Kanterman TM Vesely Graft-to-vein fistulas associated with polytetrafluoroethylene dialysis grafts: Diagnosis and clinical significance J Vasc Interv Radiol 6 1995 267 271
6. D Shaffer PN Madras ME Williams JA D'Elia A Kaldany AP Monaco Use of Dacron cuffed silicone catheters as long-term hemodialysis access ASAIO J 38 1992 55 58
7. SP Gibson D Mosquera Five years experience with the Quinton Permcath for vascular access Nephrol Dial Transplant 6 1991 269 274
8. L Purchase MH Gault Hemodialysis with a Permcath kept open with streptokinase and later citrate in a heparin-sensitive patient Nephron 58 1991 119 120
9. PG Blake S Huraib G Wu PR Uldall The use of dual lumen jugular venous catheters as definitive long term access for haemodialysis Int J Artif Organs 13 1990 26 31
10. G Dunea L Domenico P Gunnerson F Winston-Willis A survey of permanent double lumen catheters in hemodialysis patients ASAIO Trans 37 1991 M276 M277
11. NH Shusterman K Kloss JL Mullen Successful use of double-lumen, silicone rubber catheters for permanent hemodialysis access Kidney Int 35 1989 887 890
12. T Pourchez P Morinière A Fournier J Pietri Use of Permcath (Quinton) catheter in uraemic patients in whom the creation of conventional vascular access for haemodialysis is difficult Nephron 53 1989 297 302
13. S Senn Cross-Over Trials in Clinical Research 1993 Wiley Chichester, England 60 66
14. R Vanholder N Hoenich S Ringoir Morbidity and mortality of central venous catheter hemodialysis: A review of 10 years' experience Nephron 47 1987 274 279
15. SJ Schwab GL Buller RL McCann RR Bollinger DL Stickel Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use Am J Kidney Dis 11 1988 166 169
16. A Leonard FL Shapiro Subdural hematoma in regularly hemodialyzed patients Ann Intern Med 82 1975 650 658
17. K Iseki K Fukiyama Predictors of stroke in patients receiving chronic hemodialysis Kidney Int 50 1996 1672 1675
18. MJ Janssen J van der Meulen The bleeding risk in chronic haemodialysis: Preventive strategies in high-risk patients Neth J Med 48 1996 198 207
19. ZJ Twardowski High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters Am J Kidney Dis 31 1998 841 847
20. RM Prewitt C Hoy A Kong SA Gu D Greenberg R Cook SM Chan J Ducas Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator Am Rev Respir Dis 141 1990 290 295
21. SZ Goldhaber CM Kessler J Heit J Markis GVRK Sharma D Dawley JS Nagel M Meyerovitz D Kim DE Vaughan JA Parker SS Tumeh D Drum J Loscalzo K Reagan AP Selwyn J Anderson E Braunwald Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism Lancet 2 1988 293 298
22. S Gu J Ducas JN Patton D Greenberg RM Prewitt Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase Chest 101 1992 1684 1690
23. JB Atkinson HA Bagnall E Gomperts Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters J Parenter Enteral Nutr 14 1990 310 311
24. MB Stephens PV Pepper Streptokinase therapy. Recognizing and treating allergic reactions Postgrad Med 103 1998 89 90
25. NH Shusterman K Kloss JL Mullen Successful use of double-lumen, silicone rubber catheters for permanent hemodialysis access Kidney Int 35 1989 887 890